Free shipping on all orders over $ 500

LY518674

Cat. No. M10453
LY518674 Structure
Synonym:

LY-674

Size Price Availability
5mg USD 500  USD500 4-7 Days
10mg USD 870  USD870 4-7 Days
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

LY518674 is a potent and selective PPAR-alpha antagonist with EC50 of 42 nM for human PPARα. LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome. LY518674 produced a dose-dependent increase in serum HDL-c, resulting in 208 +/- 15% elevation at optimum dose. In cultured hepatocytes, LY518674 produced 50% higher apoA-1 secretion, which was associated with increase in radiolabeled methionine incorporation in apoA-1.

Chemical Information
Molecular Weight 409.48
Formula C23H27N3O4
CAS Number 425671-29-0
Solubility (25°C) DMSO ≥ 100 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Amit V Khera, et al. Eur Heart J. Potent peroxisome proliferator-activated receptor-α agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome

[2] Yalda Bravo, et al. Bioorg Med Chem Lett. Identification of the first potent, selective and bioavailable PPARα antagonist

[3] Steven E Nissen, et al. JAMA. Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials

Related PPAR Products
DSO-5a

DSO-5a is a potent, selective, orally active BB3 agonist.

Carfloglitazar sodium

Carfloglitazar sodium is a dual agonist of the pan peroxisome proliferator-activated receptor (PPARα/γ) with EC50 values of 1.2, 0.08, and 1.7 μM for PPARα, PPARγ, and PPARδ, respectively.It can be used in studies related to nonalcoholic steatohepatitis (NASH).

Seladelpar

Seladelpar is a potent, orally active, specific PPAR-δ agonist with an EC50 of 2 nM.

4'-O-Methylhonokiol

4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.

3-Phenyl-2-propen-1-ol

trans-Cinnamyl alcohol is a trans-isomer of Cinnamyl alcohol.

  Catalog
Abmole Inhibitor Catalog




Keywords: LY518674, LY-674 supplier, PPAR, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.